05/12/2006
London, UK – 5 December, 2006: ReGen Therapeutics Plc (the ‘Company’) announces that it has today received notification from Dr P. Garrod, a non-executive director, that he has acquired 500,000 ordinary shares of the Company at 1.15p per share. Dr Garrod now holds and is beneficially interested in 66,750,000 ordinary shares representing 9.61% of the current issued share capital of the
Company.
For further information, please contact:
Andrew Marshall Tel. 020 7960 6007
Greycoat Communications